-+ 0.00%
-+ 0.00%
-+ 0.00%

Nuvectis Pharma Launches Phase 1b Trial of NXP900 with Osimertinib in EGFRmut+ NSCLC

路透·12/17/2025 12:01:38

登录查看新闻详情